A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sanofi's rilzabrutinib meets primary endpoint in Phase 3 LUNA 3 study for immune thrombocytopenia; potential for clinically beneficial treatment of several immune diseases underscored, with regulatory submissions in the US and EU expected by year-end
Published: April 23, 2024 by Sanofi SA
European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC
Published: April 22, 2024 by Janssen Pharmaceutical Companies
Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications
Published: April 18, 2024 by Marketline - Deals
LA HB883: Allows the provision of data relative to sickle cell disease
Published: April 18, 2024 by Louisiana 2024 Regular Session
LA HB869: Requires continuing education for the treatment of sickle cell disease for physicians and physician assistants
Published: April 18, 2024 by Louisiana 2024 Regular Session

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count